Unknown Author
January 24, 2026
Kirkland Advises CarepathRx on Sale of BioPlus Specialty Pharmacy to Elevance Health

1 min
AI-made summary
- Kirkland & Ellis represented CarepathRx, a portfolio company of Nautic Partners, in its agreement to sell BioPlus Specialty Pharmacy to Elevance Health
- BioPlus is recognized as the nation’s largest independent specialty pharmacy, serving patients in all 50 states and across multiple therapeutic categories
- The Kirkland team included partners and associates from corporate, debt finance, tax, antitrust, and technology & IP transactions practices.
Kirkland & Ellis advised CarepathRx, a portfolio company of Nautic Partners, LLC (Nautic) and leader in pharmacy and medication management solutions, on its agreement to sell BioPlus Specialty Pharmacy, the nation’s largest independent specialty pharmacy, to Elevance Health (NYSE:ELV). BioPlus is a leading specialty pharmacy serving patients in all 50 states and across various therapeutic categories. Read the CarepathRx press release The Kirkland team was led by corporate partners Mike Sartor and Armand Della Monica and included associate William Lay, debt finance partners Jason Serlenga and John Ilardo, tax partners Rachel Cantor and Devin Heckman, antitrust partner Andrea Murino, and technology & IP transactions partners Shellie Freedman and Joanna Schlingbaum.
Article Author
Unknown Author
The Sponsor
